OXFBD04

Catalog No. :
ACWHPR076
CAS No. :
2231747-03-6
Molecular Formula :
C17H16N2O3
Molecular Weight :
296.33

IUPAC Name:3-(3,5-dimethylisoxazol-4-yl)-5-(hydroxy(pyridin-3-yl)methyl)phenol

OXFBD04 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$69.00Login to see priceInquiryInquiry
5mg98%$170.00Login to see priceInquiryInquiry
10mg98%$272.00Login to see priceInquiryInquiry
25mg98%$408.00Login to see priceInquiryInquiry
50mg98%$527.00Login to see priceInquiryInquiry
100mg98%$712.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameOXFBD04
IUPAC Name3-(3,5-dimethylisoxazol-4-yl)-5-(hydroxy(pyridin-3-yl)methyl)phenol
MDL No.MFCD32174354
Molecular FormulaC17H16N2O3
Molecular Weight296.33
SMILESOC(C1=CC=CN=C1)C2=CC(O)=CC(C3=C(ON=C3C)C)=C2
InChI KeyRFDVEAHRRMEOHK-UHFFFAOYSA-N
SynonymOXFBD04;OXFBD04,OXFBD-04;3-Pyridinemethanol, α-[3-(3,5-dimethyl-4-isoxazolyl)-5-hydroxyphenyl]-;3-(3,5-Dimethyl-4-isoxazolyl)-5-[hydroxy(3-pyridyl)methyl]phenol;OXFBD04, 10 mM in DMSO;α-[3-(3,5-Dimethyl-4-isoxazolyl)-5-hydroxyphenyl]-3-pyridinemethanol
CAS No.2231747-03-6
PubChem CID145925690

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWHPR076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHPR076 route product structure diagram
    ACWHPR0762231747-03-6
Inquiry

2. ACWHPR076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHPR076 route product structure diagram
    ACWHPR0762231747-03-6
Inquiry

Comments (0)